111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,238 full-time employees. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.
Mr. Junling Liu es el Co-Chairman of the Board de 111 Inc, se unió a la empresa desde 2015.
¿Qué tal es el rendimiento del precio de la acción YI?
El precio actual de YI es de $6.35, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de 111 Inc?
111 Inc pertenece a la industria Retail y el sector es Consumer Staples
¿Cuál es la capitalización bursátil de 111 Inc?
La capitalización bursátil actual de 111 Inc es $54.4M
¿Es 111 Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 2 analistas han realizado calificaciones de análisis para 111 Inc, incluyendo 4 fuerte compra, 4 compra, 1 mantener, 0 venta, y 4 fuerte venta